serine beta lactamase inhibitor (Venatorx)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameserine beta lactamase inhibitor (Venatorx)
Drug Alias NameVNRX-5109VNRX-5119
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsCarbapenem-Resistant InfectionBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVenatorx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVenatorx Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCarbapenem-Resistant InfectionBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A